ReviewFrontiers in endocrinology2022

Effects and mechanisms of SGLT2 inhibitors on the NLRP3 inflammasome, with a focus on atherosclerosis.

Liu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.